Europe is falling behind America in the fight against colorectal cancer.

(March 13, 2014) Annual incidence of Europe’s second most lethal cancer killer is predicted to rise by 12% by 20201 warns Europe’s largest body of gastroenterology experts, United European Gastroenterology (UEG). Colorectal cancer is estimated to claim the lives of 214,6752 adults in Europe and is expected to affect 502,000 Europeans a year by 20201.

Colorectal cancer is extremely lethal in its advanced stages yet early detection can result in a 90-95% survival rate. Early signs of colorectal cancer do not exist or are difficult to spot but can be detected via a simple screening test (the Faecal Occult Blood Test) that can be performed at home. Widely available across Europe, the FOBT is generally offered to men and women over the age of 50 via an invitation from their doctor or a national screening programme. However, uptake throughout Europe has been surprisingly low, with the percentage of eligible adults screened in many countries falling way short of the 65% rate considered desirable by the European Commission and already achieved in the USA3.

While Europe’s promotion of organised national screening programmes is seen as preferable to America’s ‘opportunistic’ approach, UEG experts say Europe can learn from the USA when it comes to pushing CRC to the forefront of public life. Annual campaigns fronted by Meryl Streep and other Hollywood stars, nationwide ‘Dress in Blue Days’ and a White House colorectal cancer statement issued by President Obama earlier this month are all helping to raise the profile of the disease and the importance of screening across the Atlantic. “United European Gastroenterology has campaigned for screening for colorectal cancer to be available to all European citizens; we are now urging the European population to participate and to be aware that FOBT screening reduces the risk of dying from colorectal cancer by 20-30%. Colorectal cancer is treatable when detected early, yet it is estimated to claim the lives of over 500 Europeans every day,” says British gastroenterologist and UEG President, Professor Michael Farthing. As the world marks Colorectal Cancer Awareness Month (March) UEG is launching a new awareness campaign, ‘Screening Saves Lives’, urging all European men and women over 50 to talk to a healthcare professional and undertake screening for colorectal cancer. #screeningsaveslives Notes to Editors

About UEG
United European Gastroenterology is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy.
Find out more about UEG’s work at Press contact Samantha Forster Tel:+44(0)1444811099 @UEGMedia References 1 International Agency for Research on Cancer (IARC) 2 Globocan Estimated Cancer Incidence, Mortality and Prevalence, 2012 3 Overall USA screening rate, Centers For Disease Control and Prevention, 2010 Download press release Colorectal cancer in Europe facts Colorectal cancer incidence and mortality in Europe How to spot colorectal cancer symptoms

The Growing Obesity Issue

Obesity, a growing problem throughout Europe, has been shown to be strongly correlated with a number of digestive health diseases.

Europe's Most Common Cancer

The prognosis for CRC is relatively good compared with other GI malignancies. However, mortality is continuing to increase in many eastern European countries.

Viral Hepatitis Infections Across Europe

Hepatitis is a viral infection most commonly contracted through unprotected sex, blood transmission, or perinatal transmission. Hepatitis B and C are the most common forms of the virus in Europe. 


The inflammatory bowel diseases, Crohn's disease and ulcerative colitis, are common, chronic inflammatory conditions that primarily affect young people in adolescence and early adulthood. Both IBD and IBS have increased in prevalence across Europe in recent decades.

Liver Disease and Liver Cancer Across Europe

Chronic liver disease has been estimated to affect almost 30 million people in the EU, while a total of 51,319 new cases of liver cancer were recorded in the EU in 2012.

Oesophageal and Gastric Cancer Across Europe

Oesophageal and gastric (stomach) cancer account for around 6% of all cancers in men and 3% of all cancers in women, which typically affect people aged between 60 and 80 years.

The Paediatric Pandemic

The current health burden and economic pressure of paediatric digestive health issues, such as rising levels of childhood obesity, have become a pandemic issue throughout the continent. 

Pancreatic Cancer Across Europe

Pancreatic cancer is the eighth most common cancer in Europe and survival rates are alarmingly low. 

Screening for Digestive Health Diseases

Various screening programmes are available throughout Europe for different areas of digestive health. 

<1 2 3 4 5 6